Dr. Martens (LON:DOCS) Stock: Insider Ije Nwokori Sells 209,160 Shares

Dr. Martens plc (LON:DOCS – Get Free Report) insider Ije Nwokori sold 209,160 shares of Dr. Martens stock in a transaction dated Friday, October 16th. The stock was sold at an average price of GBX 69, for a total value of £144,320.40.

Ije Nwokori also recently made the following trade(s):

  • On Monday, October 12th, Ije Nwokori bought 220 shares of Dr. Martens stock. The stock was acquired at an average cost of GBX 68 per share, for a total transaction of £149.60.
  • On Friday, September 11th, Ije Nwokori bought 232 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 65 per share, with a total value of £150.80.
  • On Tuesday, August 11th, Ije Nwokori purchased 179 shares of Dr. Martens stock. The shares were bought at an average cost of GBX 84 per share, with a total value of £150.36.

Dr. Martens Stock Up 0.9%

Shares of LON:DOCS traded up GBX 0.60 during midday trading on Friday, reaching GBX 68.80. The company had a trading volume of 1,484,075 shares, compared to its average volume of 6,314,625. The company has a debt-to-equity ratio of 108.85, a current ratio of 2.61 and a quick ratio of 1.13. The stock has a market capitalization of £658.53 million, a P/E ratio of 28.67, a PEG ratio of 6.40 and a beta of 0.26. Dr. Martens plc has a one year low of GBX 59.15 and a one year high of GBX 97.05. The stock’s fifty day moving average price is GBX 73.35 and its 200-day moving average price is GBX 71.05.

Wall Street Analyst Weigh In

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 110 price target on shares of Dr. Martens in a research note on Friday, October 9th. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, Dr. Martens presently has an average rating of “Moderate Buy” and a consensus target price of GBX 105.

Check Out Our Latest Analysis on DOCS

About Dr. Martens

(Get Free Report)

Dr. Martens is an iconic British footwear brand founded in Northamptonshire, England. Its first silhouette, the 1460 boot – named after the date it was produced – rolled off the production line on 1st April 1960. Originally chosen by workers for their air-cushioned comfort and durability, “Docs” or “DM’s” were later adopted by musicians and subcultural pioneers who took them from the street to the global stage.

Over six decades later, Dr. Martens operates in more than 60 countries and employs around 3,600 people.

Featured Stories

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.